Related Experiment Video

Updated: Aug 12, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Management of dyslipidemia after coronary artery bypass grafting

P Alaupovic1

  • 1Oklahoma Medical Research Foundation, Oklahoma City 73104, USA. alaupovicp@omrf.ouhsc.edu

Current Opinion in Lipidology
|August 17, 2000
PubMed

Insights

Abnormalities in plasma lipoproteins significantly accelerate atherosclerosis in vein grafts after bypass surgery. Early, aggressive pharmacological treatment of dyslipoproteinemias is crucial for graft survival.

Area of Science:

  • Cardiovascular Science
  • Lipid Metabolism
  • Vascular Biology

Background:

  • Saphenous vein grafts are susceptible to atherosclerotic attrition after coronary artery bypass grafting.
  • Plasma lipoprotein system abnormalities are a major risk factor for this graft degeneration.

Purpose of the Study:

  • To analyze the role of different lipoprotein particles in the progression of atherosclerosis in vein grafts.
  • To evaluate the impact of dyslipoproteinemia treatment on graft outcomes.

Main Methods:

  • Review of serial angiographic studies in post-coronary artery bypass grafting patients.
  • Analysis of data from intervention trials targeting lipoprotein abnormalities.

Main Results:

  • Cholesterol-rich low-density lipoprotein (LDL) and lipoprotein B particles contribute to atherosclerotic lesion progression.
  • Triglyceride-rich very low-density lipoprotein and intermediate-density lipoprotein particles also exhibit atherogenic capacity.
  • High-density lipoprotein 3 particles may offer a protective effect against atherosclerosis.

Conclusions:

  • Dyslipoproteinemias are a critical risk factor for saphenous vein graft atherosclerosis.
  • Early and aggressive pharmacological treatment of dyslipoproteinemias is essential for preserving vein graft function.
  • Targeting specific lipoprotein abnormalities can delay or prevent graft attrition.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation06:47

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft05:25

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft

Published on: September 15, 2023

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...